Our annual ranking of America's largest corporations

40 of 500
40. Pfizer
Financials: Latest Results
Rank: 40 (Previous rank: 31)
CEO: Ian C. Read
Was this company a 2011 top stock?

Pfizer took some hard hits in 2011. In November, the company's leading cholesterol drug, Lipitor, lost its patent protection, causing sales of the drug to drop 42% in the U.S. compared to the previous year, according to the company's Q4 earnings report. The company ended the year in a rough spot, with fourth quarter earnings dropping nearly 50% from 2010. Last summer, Pfizer announced that it is looking to sell some of its more profitable units, including its infant nutrition and animal health businesses, as part of an effort to turn more of the company's attention toward new drug development. The company recently announced that it will sell its infant nutrition unit to Nestle for $11.9 billion.

Subscribe to Fortune Magazine
Key financials $ millions % change
from 2010
Revenues 67,932.0 0.2
Profits 10,009.0 21.2
Assets 188,002.0
Stockholders' equity 82,190.0
Market value (3/29/2012) 169,013.6
Profits as % of  
Revenues 14.7
Assets 5.3
Stockholders' equity 12.2
Earnings per share  
2011 $ 1.27
% change from 2010 24.5
2001-2011 annual growth rate % 0.4
Total return to investors %
2011 28.7
2001-2011 annual rate -2.3
Industry: Pharmaceuticals
Rank Company 500
($ millions)
1 Pfizer 40 67,932.0
2 Johnson & Johnson 42 65,030.0
3 Merck 57 48,047.0
4 Abbott Laboratories 71 38,851.3
5 Eli Lilly 119 24,286.5
6 Bristol-Myers Squibb 134 21,244.0
7 Amgen 168 15,582.0
8 Gilead Sciences 306 8,385.4
9 Mylan 396 6,129.8
10 Allergan 448 5,419.1
11 Biogen Idec 476 5,048.6
12 Celgene 492 4,842.1
Issue date: May 21, 2012
Includes revenues from discontinued operations.
Galleries and more
235 E. 42nd St.
New York, NY 10017
What do you think about Pfizer?
Fortune 500+
Want more on America's top companies? Get data on the full Fortune 1,000 list here. Fortune 500+

Rank # of Fortune 500 Companies
California 53
Texas 52
New York 50
Company Rank
Google 73
NetApp 474
NuStar Energy 377
Company 2011 $ (millions)
Exxon $41,060.0
Chevron $26,895.0
Apple $25,922.0
FAQ and methodology
Included in the survey are U.S. incorporated companies filing financial statements with a government agency. This includes private companies... More
Current Issue
  • Give the gift of Fortune
  • Get the Fortune app
  • Subscribe

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer. Morningstar: © 2018 Morningstar, Inc. All Rights Reserved. Factset: FactSet Research Systems Inc. 2018. All rights reserved. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2018 and/or its affiliates.